Emmanuel Roze Selected Research

Myoclonic dystonia

1/2019	Long-term GPi-DBS improves motor features in myoclonus-dystonia and enhances social adjustment.
1/2018	Myoclonus-dystonia: classification, phenomenology, pathogenesis, and treatment.
5/2016	A randomized, controlled, double-blind, crossover trial of zonisamide in myoclonus-dystonia.
6/2015	Pallidal activity in myoclonus dystonia correlates with motor signs.
1/2011	Bilateral deep brain stimulation of the pallidum for myoclonus-dystonia due to ε-sarcoglycan mutations: a pilot study.
10/2008	Myoclonus-dystonia due to maternal uniparental disomy.
4/2008	Cortical excitability in DYT-11 positive myoclonus dystonia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Emmanuel Roze Research Topics

Disease

14	Parkinson Disease (Parkinson's Disease) 01/2022 - 04/2008
12	Movement Disorders (Movement Disorder) 01/2022 - 04/2008
11	Dystonia (Limb Dystonia) 01/2021 - 02/2006
9	Parkinsonian Disorders (Parkinsonism) 01/2020 - 10/2008
7	Dystonic Disorders (Writer's Cramp) 01/2020 - 07/2009
7	Myoclonic dystonia 01/2019 - 04/2008
6	Dyskinesias (Dyskinesia) 01/2022 - 02/2006
6	Glut1 Deficiency Syndrome 01/2020 - 01/2015
6	Myoclonus (Nocturnal Myoclonus) 10/2019 - 10/2007
6	Tremor (Tremors) 01/2018 - 10/2007
6	Huntington Disease (Huntington's Disease) 06/2011 - 01/2008
5	Nervous System Diseases (Neurological Disorders) 01/2021 - 12/2008
4	Epilepsy (Aura) 10/2019 - 12/2008
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018 - 04/2008
4	Cerebellar Ataxia (Dysmetria) 01/2018 - 06/2015
3	Chorea (Rheumatic Chorea) 01/2021 - 02/2011
3	Dementia (Dementias) 10/2020 - 10/2008
3	Tourette Syndrome (Tourette's Syndrome) 01/2020 - 02/2016
3	Alternating hemiplegia of childhood 10/2017 - 01/2015
3	Muscle Hypotonia (Hypotonia) 12/2014 - 02/2006
2	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 11/2021 - 12/2018
2	Disease Progression 01/2021 - 01/2016
2	Autonomic Nervous System Diseases (Dysautonomia) 10/2020 - 01/2018
2	Seizures (Absence Seizure) 10/2019 - 12/2008
2	Intellectual Disability (Idiocy) 10/2019 - 07/2009
2	Hallucinations (Hallucination) 01/2018 - 05/2011
2	Paralysis (Palsy) 01/2018 - 09/2013
2	Cerebellar Diseases (Cerebellar Syndrome) 01/2018 - 01/2018
2	Dystonia 12 12/2015 - 10/2008
2	Atrophy 12/2014 - 06/2011
2	Ataxia (Dyssynergia) 10/2013 - 12/2010
2	due to Sepiapterin Reductase Deficiency Dopa-Responsive Dystonia 04/2012 - 03/2010
2	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 08/2010 - 10/2008
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2022
1	Dizziness (Lightheadedness) 01/2022
1	Dysphonia (Spastic Dysphonia) 01/2021
1	Infections 01/2021
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2021
1	Pantothenate Kinase-Associated Neurodegeneration (Hallervorden-Spatz Disease) 01/2021
1	Neurodegeneration with brain iron accumulation (NBIA) 01/2020
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2020
1	Leukoencephalopathies 12/2019
1	Hypokinesia (Bradykinesia) 11/2019
1	Deafness (Deaf Mutism) 10/2019
1	Nonsyndromic Deafness 10/2019
1	Chronic Brain Damage 10/2019
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2019
1	Whipple Disease (Whipple's Disease) 11/2018
1	Type C Niemann-Pick Disease (Niemann Pick Disease, Type C) 10/2018
1	Type 1 Episodic Ataxia 01/2018
1	Apraxias (Dyspraxia) 01/2018
1	Kearns-Sayre Syndrome 01/2018
1	Learning Disabilities (Learning Disability) 01/2018
1	autosomal recessive 1 Spinocerebellar ataxia 01/2018
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2018
1	Xanthomatosis (Xanthoma) 01/2018
1	Colorectal Neoplasms (Colorectal Cancer) 01/2018

Drug/Important Bio-Agent (IBA)

13	Levodopa (L Dopa)FDA LinkGeneric 11/2021 - 02/2006
5	triheptanoinIBA 01/2020 - 05/2016
5	Sarcoglycans (beta Sarcoglycan)IBA 01/2019 - 04/2008
4	polyglutamineIBA 06/2011 - 01/2008
3	Apomorphine FDA Link 01/2022 - 06/2016
3	Dopamine Agonists (Dopamine Agonist)IBA 11/2021 - 05/2010
3	Proteins (Proteins, Gene)FDA Link 10/2019 - 06/2015
3	Therapeutic UsesIBA 01/2018 - 09/2013
3	Huntingtin ProteinIBA 06/2011 - 01/2008
3	Dihydroxyphenylalanine (Dopa)IBA 03/2010 - 10/2008
2	Caffeine (No Doz)FDA LinkGeneric 01/2022 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 10/2008
2	Opioid Receptors (Opioid Receptor)IBA 01/2019 - 12/2018
2	AntibodiesIBA 01/2018 - 01/2018
2	Acetazolamide (Diamox)FDA LinkGeneric 01/2018 - 02/2011
2	Zonisamide (Zonegran)FDA LinkGeneric 01/2018 - 05/2016
2	Glucose Transporter Type 1IBA 07/2017 - 01/2016
2	Bee Venoms (Bee Venom)IBA 01/2016 - 01/2016
2	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 01/2016 - 10/2008
2	Dopamine (Intropin)FDA LinkGeneric 03/2011 - 07/2009
2	Guanosine Triphosphate (GTP)IBA 07/2009 - 12/2008
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	fosmetpantotenateIBA 01/2021
1	Member 2 Group A Nuclear Receptor Subfamily 4IBA 01/2020
1	Explosive Agents (Explosives)IBA 01/2020
1	IronIBA 01/2020
1	Leucovorin (Folinic Acid)FDA Link 01/2019
1	LipidsIBA 10/2018
1	miglustat (Zavesca)FDA Link 10/2018
1	Biological ProductsIBA 01/2018
1	BenzodiazepinesIBA 01/2018
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2018
1	AminopyridinesIBA 01/2018

Therapy/Procedure

10	Deep Brain Stimulation 01/2022 - 12/2006
10	Therapeutics 11/2021 - 08/2008
5	Ketogenic Diet 01/2020 - 01/2015
3	Denervation 01/2017 - 09/2008
3	Transcranial Magnetic Stimulation 01/2017 - 09/2013
1	Precision Medicine 01/2021
1	Transitional Care 01/2021
1	Stem Cell Transplantation 12/2019